37 studies found for:    "friedreich ataxia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
2 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
3 Completed Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
Condition: Friedreich Ataxia
Intervention:
4 Not yet recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
5 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
6 Recruiting EPI-743 in Friedreich's Ataxia Point Mutations
Condition: Friedreich's Ataxia
Intervention: Drug: EPI-743
7 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
8 Completed Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
9 Completed Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Condition: Friedreich's Ataxia
Interventions: Drug: pioglitazone;   Drug: Placebo
10 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
11 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
12 Completed
Has Results
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
13 Completed Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
14 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
15 Completed
Has Results
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Idebenone;   Drug: Placebo
16 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
17 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
18 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: RTA 408 Capsules, 2.5 mg;   Drug: RTA 408 Capsules, 5 mg;   Drug: RTA 408 Capsules, 10 mg;   Drug: Placebo
19 Active, not recruiting Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
20 Active, not recruiting Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Placebo;   Drug: EPI-743 400 mg;   Drug: EPI-743 200 mg

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years